509 related articles for article (PubMed ID: 27283218)
1. Comparative analysis of the effect of prostatic invasion patterns on cancer-specific mortality after radical cystectomy in pT4a urothelial carcinoma of the bladder.
Vallo S; Gilfrich C; Burger M; Volkmer B; Boehm K; Rink M; Chun FK; Roghmann F; Novotny V; Mani J; Brisuda A; Mayr R; Stredele R; Noldus J; Schnabel M; May M; Fritsche HM; Pycha A; Martini T; Wirth M; Roigas J; Bastian PJ; Nuhn P; Dahlem R; Haferkamp A; Fisch M; Aziz A
Urol Oncol; 2016 Oct; 34(10):432.e1-8. PubMed ID: 27283218
[TBL] [Abstract][Full Text] [Related]
2. Concomitant seminal vesicle invasion in pT4a urothelial carcinoma of the bladder with contiguous prostatic infiltration is an adverse prognosticator for cancer-specific survival after radical cystectomy.
May M; Brookman-May S; Burger M; Gilfrich C; Fritsche HM; Rink M; Chun F; Fisch M; Roghmann F; Noldus J; Mayr R; Pycha A; Novotny V; Wirth M; Vallo S; Haferkamp A; Roigas J; Brisuda A; Stredele R; Volkmer B; Dechet C; Schnabel M; Denzinger S; Stief CG; Bastian PJ; Aziz A
Ann Surg Oncol; 2014 Nov; 21(12):4034-40. PubMed ID: 24895114
[TBL] [Abstract][Full Text] [Related]
3. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making.
Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M
BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844
[TBL] [Abstract][Full Text] [Related]
4. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842
[TBL] [Abstract][Full Text] [Related]
5. Is stage pT4a (D1) reliable in assessing transitional cell carcinoma involvement of the prostate in patients with a concurrent bladder cancer? A necessary distinction for contiguous or noncontiguous involvement.
Pagano F; Bassi P; Ferrante GL; Piazza N; Abatangelo G; Pappagallo GL; Garbeglio A
J Urol; 1996 Jan; 155(1):244-7. PubMed ID: 7490845
[TBL] [Abstract][Full Text] [Related]
6. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.
May M; Bastian PJ; Brookman-May S; Fritsche HM; Tilki D; Otto W; Bolenz C; Gilfrich C; Trojan L; Herrmann E; Moritz R; Tiemann A; Müller SC; Ellinger J; Buchner A; Stief CG; Wieland WF; Höfner T; Hohenfellner M; Haferkamp A; Roigas J; Zacharias M; Nuhn P; Burger M
Urol Oncol; 2013 Oct; 31(7):1141-7. PubMed ID: 22056404
[TBL] [Abstract][Full Text] [Related]
7. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.
Patel AR; Cohn JA; Abd El Latif A; Miocinovic R; Steinberg GD; Paner GP; Hansel DE
J Urol; 2013 Jan; 189(1):53-8. PubMed ID: 23164389
[TBL] [Abstract][Full Text] [Related]
8. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
Zhang M; Tao R; Zhang C; Shen Z
Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
[TBL] [Abstract][Full Text] [Related]
9. Radical Cystectomy in Pathological T4a and T4b Bladder Cancer Patients: Is There Any Space for Sub Stratification?
Moschini M; Zamboni S; Mattei A; Baumeister P; Di Bona C; Cornelius J; Shariat SF; Freschi M; Zaffuto E; Salonia A; Montorsi F; Briganti A; Colombo R; Gallina A;
Urol Int; 2019; 102(3):269-276. PubMed ID: 30695782
[TBL] [Abstract][Full Text] [Related]
10. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant cisplatin-based combined chemotherapy for lymph node (LN)-positive urothelial carcinoma of the bladder (UCB) after radical cystectomy (RC): a retrospective international study of >1500 patients.
Lucca I; Rouprêt M; Kluth L; Rink M; Tilki D; Fajkovic H; Kassouf W; Hofbauer SL; de Martino M; Karakiewicz PI; Briganti A; Trinh QD; Seitz C; Fritsche HM; Burger M; Lotan Y; Kramer G; Shariat SF; Klatte T
BJU Int; 2015 May; 115(5):722-7. PubMed ID: 24905084
[TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
[TBL] [Abstract][Full Text] [Related]
13. Transitional cell carcinoma involving the prostate: a clinicopathological retrospective study of 76 cases.
Njinou Ngninkeu B; Lorge F; Moulin P; Jamart J; Van Cangh PJ
J Urol; 2003 Jan; 169(1):149-52. PubMed ID: 12478124
[TBL] [Abstract][Full Text] [Related]
14. Urothelial carcinoma involving the prostate: the association of revised tumour stage and coexistent bladder cancer with survival after radical cystectomy.
Knoedler JJ; Boorjian SA; Tollefson MK; Cheville JC; Thapa P; Tarrell RF; Frank I
BJU Int; 2014 Dec; 114(6):832-6. PubMed ID: 24119219
[TBL] [Abstract][Full Text] [Related]
15. Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: a population-based study.
Berman DM; Kawashima A; Peng Y; Mackillop WJ; Siemens DR; Booth CM
Int J Urol; 2015 Feb; 22(2):163-70. PubMed ID: 25197026
[TBL] [Abstract][Full Text] [Related]
16. Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy.
da Silva RD; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Chade D; Guglielmetti GB; Pycha A; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Zerbib M; Scherr DS; Shariat SF
J Urol; 2013 Aug; 190(2):487-92. PubMed ID: 23395802
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy.
Shariat SF; Bolenz C; Godoy G; Fradet Y; Ashfaq R; Karakiewicz PI; Isbarn H; Jeldres C; Rigaud J; Sagalowsky AI; Lotan Y
J Urol; 2009 Jul; 182(1):78-84; discussion 84. PubMed ID: 19447418
[TBL] [Abstract][Full Text] [Related]
18. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW
J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
[TBL] [Abstract][Full Text] [Related]
19. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
[TBL] [Abstract][Full Text] [Related]
20. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy.
Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
